1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Healthcare-associated infections

Faecal microbiota transplant for recurrent or refractory Clostridioides difficile infection

Medtech innovation briefing [MIB247] Published date: 02 February 2021

  • Overview
  • Summary
  • The procedure
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Expert comments
  • Patient organisation comments
  • Expert commentators
  • Development of this briefing
Download (PDF)

Advice

  • Next

NICE has developed a medtech innovation briefing (MIB) on faecal microbiota transplant for recurrent or refractory Clostridioides difficile infection.

What are MIBs?


  • Next